Extranodal NK-/T-Cell Lymphoma, Nasal Type

Extranodal NK-/T-Cell Lymphoma, Nasal Type — Trials · CancerIndex

Clinical trials

Registered studies

23 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2
Recruiting: 1
Ph III recruiting: 0
Growth YoY: —
Industry share: 100%
Top sponsor: Dren Bio
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (4)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02733458	GELAD Chemotherapy and Sandwiched Radiotherapy in the Treatment of Stage IE/IIE Natural Killer/T-cell Lymphoma	completed	N/A	52	Xinhua Hospital, Shanghai Jiao Tong University School of MedicineOTHER	1	Sep 14, 2021	clinicaltrials
NCT02764281	MEDA Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation for Stage IV Natural Killer/T-cell Lymphoma	completed	N/A	53	Xinhua Hospital, Shanghai Jiao Tong University School of MedicineOTHER